155 related articles for article (PubMed ID: 23380602)
1. The evolving molecular genetic landscape in acute myeloid leukaemia.
Sanders MA; Valk PJ
Curr Opin Hematol; 2013 Mar; 20(2):79-85. PubMed ID: 23380602
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity and clonal evolution in acute myeloid leukemia.
Romer-Seibert JS; Meyer SE
Curr Opin Hematol; 2021 Jan; 28(1):64-70. PubMed ID: 33186150
[TBL] [Abstract][Full Text] [Related]
3. Driver mutations in acute myeloid leukemia.
Kishtagari A; Levine RL; Viny AD
Curr Opin Hematol; 2020 Mar; 27(2):49-57. PubMed ID: 31972687
[TBL] [Abstract][Full Text] [Related]
4. The power and potential of integrated diagnostics in acute myeloid leukaemia.
Haferlach T; Schmidts I
Br J Haematol; 2020 Jan; 188(1):36-48. PubMed ID: 31808952
[TBL] [Abstract][Full Text] [Related]
5. Immune control in Acute Myeloid Leukaemia.
Straube J; Janardhanan Y; Haldar R; Bywater MJ
Exp Hematol; 2024 Jun; ():104256. PubMed ID: 38876254
[TBL] [Abstract][Full Text] [Related]
6. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.
; Ley TJ; Miller C; Ding L; Raphael BJ; Mungall AJ; Robertson A; Hoadley K; Triche TJ; Laird PW; Baty JD; Fulton LL; Fulton R; Heath SE; Kalicki-Veizer J; Kandoth C; Klco JM; Koboldt DC; Kanchi KL; Kulkarni S; Lamprecht TL; Larson DE; Lin L; Lu C; McLellan MD; McMichael JF; Payton J; Schmidt H; Spencer DH; Tomasson MH; Wallis JW; Wartman LD; Watson MA; Welch J; Wendl MC; Ally A; Balasundaram M; Birol I; Butterfield Y; Chiu R; Chu A; Chuah E; Chun HJ; Corbett R; Dhalla N; Guin R; He A; Hirst C; Hirst M; Holt RA; Jones S; Karsan A; Lee D; Li HI; Marra MA; Mayo M; Moore RA; Mungall K; Parker J; Pleasance E; Plettner P; Schein J; Stoll D; Swanson L; Tam A; Thiessen N; Varhol R; Wye N; Zhao Y; Gabriel S; Getz G; Sougnez C; Zou L; Leiserson MD; Vandin F; Wu HT; Applebaum F; Baylin SB; Akbani R; Broom BM; Chen K; Motter TC; Nguyen K; Weinstein JN; Zhang N; Ferguson ML; Adams C; Black A; Bowen J; Gastier-Foster J; Grossman T; Lichtenberg T; Wise L; Davidsen T; Demchok JA; Shaw KR; Sheth M; Sofia HJ; Yang L; Downing JR; Eley G
N Engl J Med; 2013 May; 368(22):2059-74. PubMed ID: 23634996
[TBL] [Abstract][Full Text] [Related]
7. Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.
Tarlock K; Meshinchi S
Pediatr Clin North Am; 2015 Feb; 62(1):75-93. PubMed ID: 25435113
[TBL] [Abstract][Full Text] [Related]
8. The changing mutational landscape of acute myeloid leukemia and myelodysplastic syndrome.
Larsson CA; Cote G; Quintás-Cardama A
Mol Cancer Res; 2013 Aug; 11(8):815-27. PubMed ID: 23645565
[TBL] [Abstract][Full Text] [Related]
9. Molecular therapy for acute myeloid leukaemia.
Coombs CC; Tallman MS; Levine RL
Nat Rev Clin Oncol; 2016 May; 13(5):305-18. PubMed ID: 26620272
[TBL] [Abstract][Full Text] [Related]
10. Acute myeloid leukemia: 2013 update on risk-stratification and management.
Estey EH
Am J Hematol; 2013 Apr; 88(4):318-27. PubMed ID: 23526416
[TBL] [Abstract][Full Text] [Related]
11. Role of genotype-based approach in the clinical management of adult acute myeloid leukemia with normal cytogenetics.
Cagnetta A; Adamia S; Acharya C; Patrone F; Miglino M; Nencioni A; Gobbi M; Cea M
Leuk Res; 2014 Jun; 38(6):649-59. PubMed ID: 24726781
[TBL] [Abstract][Full Text] [Related]
12. Mutations in epigenetic modifiers in the pathogenesis and therapy of acute myeloid leukemia.
Abdel-Wahab O; Levine RL
Blood; 2013 May; 121(18):3563-72. PubMed ID: 23640996
[TBL] [Abstract][Full Text] [Related]
13. Genetic predisposition syndromes: when should they be considered in the work-up of MDS?
Babushok DV; Bessler M
Best Pract Res Clin Haematol; 2015 Mar; 28(1):55-68. PubMed ID: 25659730
[TBL] [Abstract][Full Text] [Related]
14. Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove CS; Vassiliou GS
Dis Model Mech; 2014 Aug; 7(8):941-51. PubMed ID: 25056697
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic landscape of acute myeloid leukemia.
Conway O'Brien E; Prideaux S; Chevassut T
Adv Hematol; 2014; 2014():103175. PubMed ID: 24778653
[TBL] [Abstract][Full Text] [Related]
16. Somatic characterization of pediatric acute myeloid leukemia using next-generation sequencing.
Schuback HL; Arceci RJ; Meshinchi S
Semin Hematol; 2013 Oct; 50(4):325-32. PubMed ID: 24246700
[TBL] [Abstract][Full Text] [Related]
17. Molecular targeting in acute myeloid leukemia.
Lim SH; Dubielecka PM; Raghunathan VM
J Transl Med; 2017 Aug; 15(1):183. PubMed ID: 28851395
[TBL] [Abstract][Full Text] [Related]
18. Preleukemia: one name, many meanings.
Koeffler HP; Leong G
Leukemia; 2017 Mar; 31(3):534-542. PubMed ID: 27899806
[TBL] [Abstract][Full Text] [Related]
19. Genomic Classification and Prognosis in Acute Myeloid Leukemia.
Papaemmanuil E; Gerstung M; Bullinger L; Gaidzik VI; Paschka P; Roberts ND; Potter NE; Heuser M; Thol F; Bolli N; Gundem G; Van Loo P; Martincorena I; Ganly P; Mudie L; McLaren S; O'Meara S; Raine K; Jones DR; Teague JW; Butler AP; Greaves MF; Ganser A; Döhner K; Schlenk RF; Döhner H; Campbell PJ
N Engl J Med; 2016 Jun; 374(23):2209-2221. PubMed ID: 27276561
[TBL] [Abstract][Full Text] [Related]
20. AML evolution from preleukemia to leukemia and relapse.
Shlush LI; Mitchell A
Best Pract Res Clin Haematol; 2015; 28(2-3):81-9. PubMed ID: 26590763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
